ARPA-H awards $125M for manufacturing custom RNA therapies on demand
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"ARPA-H awards $125M for manufacturing custom RNA therapies on demand" is generating significant coverage in the Business category, with 5 articles from 5 distinct sources tracked by PULSE so far.
Outlets currently covering the story include pharmaphorum, Newswise, TradingView and STAT. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 10h ago.
Quick answers
Why is "ARPA-H awards $125M for manufacturing custom RNA therapies on demand" trending?
Because 5 independent news sources published 5 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (7)
- ARPA-H Funds HMS-Led Pilot Project to Develop New Class of RNA Medicines Harvard Medical School · 1d ago
- ARPA-H backs five teams with $125m to make RNA meds on demand The Pharma Letter · 1d ago
- US puts $125m into personalised RNA therapy production pharmaphorum · 1d ago
- ARPA-H Funds HMS-Led Pilot Project To Develop New Class of RNA Medicines Newswise · 1d ago
- Waterfall Scientific Awarded $54.5 Mln To Lead Consortium For Cell-Free mRNA Manufacturing TradingView · 1d ago
- ARPA-H funds biotechs working on custom RNA therapies STAT · 1d ago
- ARPA-H awards $125M for manufacturing custom RNA therapies on demand Endpoints News · 1d ago
Topics
Related trends
Scientists design new RNA therapy to bypass mutations behind thousands of genetic diseases
3 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
New lipid nanoparticle delivers capped circular RNA for longer-lasting gene expression
5 news sources are covering this Science story right now — PULSE is tracking how fast it spreads.
A ribozyme ligase that requires a 3′ terminal phosphate on its RNA substrate
A protein‑free ribozyme ligase that seeks out and repairs broken RNA reshapes ideas about early life and genome maintenance.
In a 3.5-billion-year-old clay-rich rock from Gale Crater, NASA’s Curiosity rover identified 21 carbon-based molecules — including a nitrogen-bearing ring structure linked to the chemistry that can precede RNA and DNA
7 news sources are covering this Science story right now — PULSE is tracking how fast it spreads.
Single-cell RNA sequencing of terminal ileal biopsies identifies signatures of Crohn’s disease pathogenesis
12 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.